Mukowiscydoza
Diagnostyka i diagnoza
Diagnostyka mukowiscydozy (CF) jest procesem wieloetapowym, rozpoczynającym się od obowiązkowych badań przesiewowych noworodków, które polegają na oznaczeniu stężenia immunoreaktywnego trypsynogenu (IRT) we krwi w pierwszych 2-3 dniach życia. Podwyższony poziom IRT wymaga dalszej diagnostyki, w tym testu chlorkowego potu, uznawanego za złoty standard, gdzie stężenie jonów chlorkowych ≥ 60 mmol/L wskazuje na bardzo prawdopodobną diagnozę CF. W diagnostyce uzupełniającej stosuje się badania genetyczne identyfikujące mutacje genu CFTR, testy funkcji płuc (spirometria), badania obrazowe (RTG, TK klatki piersiowej, rentgen zatok), posiew plwociny oraz oceny funkcji trzustki (elastaza w kale, steatorrhea) i metabolizmu (OGTT w kierunku CFRD). W przypadkach niejednoznacznych pomocne są specjalistyczne testy funkcjonalne, takie jak różnica potencjałów w nabłonku nosa (NPD) i pomiar prądu jelitowego (ICM).
- Diagnostyka mukowiscydozy
- Badania przesiewowe noworodków
- Test chlorkowy potu
- Badania genetyczne
- Diagnostyka u starszych dzieci i dorosłych
- Dodatkowe badania diagnostyczne
- Badania czynności płuc
- Badania obrazowe
- Badania mikrobiologiczne
- Badania trzustki i układu pokarmowego
- Badania krwi
- Inne specjalistyczne badania
- Kryteria diagnostyczne
- Diagnostyka prenatalna
- Wyzwania w diagnostyce mukowiscydozy
- Podsumowanie procesu diagnostycznego
Diagnostyka mukowiscydozy
Diagnoza mukowiscydozy (ang. cystic fibrosis, CF) jest procesem wieloetapowym, który zazwyczaj obejmuje badania przesiewowe noworodków, testy genetyczne, test chlorkowy potu oraz ocenę kliniczną. Wczesne rozpoznanie choroby ma kluczowe znaczenie dla rozpoczęcia odpowiedniego leczenia, które może poprawić funkcję płuc, stan odżywienia oraz jakość i długość życia pacjentów.123
Badania przesiewowe noworodków
W Stanach Zjednoczonych oraz wielu innych krajach, w tym w Polsce, przeprowadza się obowiązkowe badania przesiewowe noworodków w kierunku mukowiscydozy. Badanie to jest wykonywane w pierwszych 2-3 dniach życia i polega na pobraniu kilku kropel krwi z pięty dziecka.12
Pierwszym etapem badania przesiewowego jest oznaczenie stężenia immunoreaktywnego trypsynogenu (IRT) we krwi. IRT jest prekursorem enzymu trypsynowego uwalnianym przez trzustkę, a jego podwyższony poziom może wskazywać na mukowiscydozę. Podwyższone stężenie IRT nie oznacza jednak jednoznacznie, że dziecko ma mukowiscydozę – wymaga to dalszych badań potwierdzających.123
Jeśli poziom IRT jest podwyższony, przeprowadza się dalsze badania, które mogą obejmować analizę DNA w poszukiwaniu mutacji genu CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) odpowiedzialnego za mukowiscydozę.12
Test chlorkowy potu
Test chlorkowy potu jest uznawany za „złoty standard” w diagnostyce mukowiscydozy i jest najważniejszym badaniem potwierdzającym rozpoznanie choroby. Jest wykonywany, gdy badanie przesiewowe noworodka daje wynik pozytywny lub gdy występują objawy kliniczne sugerujące mukowiscydozę.123
Test polega na stymulacji pocenia się poprzez jonoforezę pilokarpinową – na skórę przedramienia (lub uda u małych dzieci) nakłada się roztwór, który pod wpływem niewielkiego prądu elektrycznego stymuluje gruczoły potowe. Pot jest następnie zbierany na gazik lub specjalną spiralę i analizowany pod kątem zawartości jonów chlorkowych.12
Interpretacja wyników testu chlorkowego potu:123
- Stężenie jonów chlorkowych ≥ 60 mmol/L – diagnoza mukowiscydozy jest bardzo prawdopodobna
- Stężenie 30-59 mmol/L – wynik niejednoznaczny, wymagane dalsze badania
- Stężenie < 30 mmol/L – diagnoza mukowiscydozy jest mało prawdopodobna
Badania genetyczne
Badania genetyczne są istotnym elementem diagnostyki mukowiscydozy. Umożliwiają identyfikację mutacji w genie CFTR, które są odpowiedzialne za rozwój choroby. Zidentyfikowano ponad 2000 różnych mutacji genu CFTR, przy czym u większości pacjentów z CF można zidentyfikować dwie mutacje tego genu.12
Badania genetyczne są również wykorzystywane w celu:12
- Potwierdzenia diagnozy po pozytywnym wyniku testu chlorkowego potu
- Identyfikacji nosicieli mutacji, którzy nie mają objawów choroby
- Badań prenatalnych
- Określenia dokładnego rodzaju mutacji, co może pomóc w doborze odpowiedniego leczenia
Diagnostyka u starszych dzieci i dorosłych
Choć większość przypadków mukowiscydozy jest diagnozowana w okresie noworodkowym lub wczesnego dzieciństwa, u niektórych osób choroba może zostać rozpoznana w późniejszym wieku. Osoby z łagodniejszymi postaciami mukowiscydozy mogą nie wykazywać typowych objawów we wczesnym dzieciństwie, a ich diagnoza może być opóźniona.12
U starszych dzieci i dorosłych z podejrzeniem mukowiscydozy zaleca się przeprowadzenie testu chlorkowego potu oraz badań genetycznych. Szczególnie podejrzani powinni być pacjenci z nawracającymi infekcjami płuc, przewlekłym zapaleniem zatok, rozstrzeniami oskrzeli, zapaleniem trzustki czy niepłodnością u mężczyzn.12
Dodatkowe badania diagnostyczne
Oprócz podstawowych testów diagnostycznych, w procesie diagnozowania mukowiscydozy oraz monitorowania stanu pacjenta stosuje się szereg dodatkowych badań.12
Badania czynności płuc
Testy funkcji płuc (PFT – Pulmonary Function Tests) są kluczowe w ocenie stopnia uszkodzenia płuc oraz monitorowaniu postępu choroby. Badania spirometryczne dostarczają informacji na temat objętości płuc i przepływu powietrza przez drogi oddechowe.12
Badania obrazowe
Badania obrazowe stosowane w diagnostyce mukowiscydozy obejmują:12
- Rentgen klatki piersiowej – umożliwia ocenę zmian w płucach, takich jak rozstrzenia oskrzeli czy nacieki zapalne
- Tomografia komputerowa (CT) klatki piersiowej – dostarcza bardziej szczegółowych informacji o stanie płuc
- Rentgen zatok – pomaga w ocenie zapalenia zatok przynosowych
- Badania obrazowe jamy brzusznej – służą do oceny stanu trzustki, wątroby i innych narządów układu pokarmowego
Badania mikrobiologiczne
Posiew plwociny jest ważnym badaniem w diagnostyce i monitorowaniu mukowiscydozy. Pozwala na identyfikację bakterii kolonizujących drogi oddechowe pacjenta oraz określenie ich wrażliwości na antybiotyki, co pomaga w doborze odpowiedniego leczenia przeciwbakteryjnego.12
Badania trzustki i układu pokarmowego
W celu oceny funkcji trzustki i układu pokarmowego wykonuje się:12
- Badanie elastazy trzustkowej w kale – niski poziom elastazy wskazuje na niewydolność zewnątrzwydzielniczą trzustki
- Badanie zawartości tłuszczu w kale – podwyższona ilość tłuszczu w kale (steatorrhea) sugeruje zaburzenia wchłaniania
- Doustny test tolerancji glukozy (OGTT) – służy do wykrywania cukrzycy związanej z mukowiscydozą (CFRD)
Badania krwi
Badania krwi wykonywane u pacjentów z mukowiscydozą obejmują:12
- Morfologię krwi – ocena parametrów stanu zapalnego
- Poziom witamin rozpuszczalnych w tłuszczach (A, D, E, K) – często obniżony z powodu zaburzeń wchłaniania
- Poziom elektrolitów – kontrola równowagi elektrolitowej
- Próby wątrobowe – ocena funkcji wątroby
- Panel lipidowy – ocena gospodarki lipidowej
- Poziom immunoglobulin – ocena odpowiedzi immunologicznej
Inne specjalistyczne badania
Badanie różnicy potencjałów w nabłonku nosa
Badanie różnicy potencjałów w nabłonku nosa (Nasal Potential Difference, NPD) jest specjalistycznym testem funkcjonalnym, który mierzy różnicę potencjałów elektrycznych wytwarzanych przez transport jonów przez błonę śluzową nosa. Jest stosowane w diagnostyce przypadków niejednoznacznych, gdy test chlorkowy potu daje wyniki graniczne, a badania genetyczne nie wykazują jednoznacznie dwóch mutacji genu CFTR.12
Pomiar prądu jelitowego
Pomiar prądu jelitowego (Intestinal Current Measurement, ICM) jest badaniem oceniającym funkcję kanałów jonowych w błonie śluzowej jelita. Podobnie jak NPD, jest stosowany w diagnostyce niejednoznacznych przypadków mukowiscydozy.12
Kryteria diagnostyczne
Według aktualnych wytycznych Cystic Fibrosis Foundation, diagnoza mukowiscydozy opiera się na:123
- Objawach klinicznych zgodnych z chorobą lub pozytywnym wyniku badania przesiewowego noworodków lub dodatniej historii rodzinnej
- Obiektywnych dowodach dysfunkcji białka CFTR, takich jak:
- Poziom chlorków w pocie ≥ 60 mmol/L
- Identyfikacja dwóch mutacji genu CFTR powodujących chorobę
- Nieprawidłowy wynik pomiaru różnicy potencjałów w nabłonku nosa lub pomiaru prądu jelitowego
Przypadki niejasne diagnostycznie
W niektórych przypadkach, szczególnie u pacjentów z łagodniejszymi postaciami choroby, diagnoza może być niejednoznaczna. Dla takich sytuacji wprowadzono terminy:12
- CFTR-Related Metabolic Syndrome (CRMS) / CF Screen Positive, Inconclusive Diagnosis (CFSPID) – termin stosowany dla noworodków z pozytywnym wynikiem badania przesiewowego, ale bez jednoznacznych dowodów na mukowiscydozę
- CFTR-Related Disorder (CFRD) – termin określający monosymptomatyczne jednostki kliniczne (takie jak obustronny wrodzony brak nasieniowodów, zapalenie trzustki, rozstrzenia oskrzeli) związane z dysfunkcją CFTR, które nie spełniają kryteriów diagnostycznych CF
Diagnostyka prenatalna
Diagnostyka prenatalna mukowiscydozy jest możliwa w przypadku, gdy oboje rodzice są nosicielami mutacji genu CFTR. Dostępne są dwie metody badań prenatalnych:12
- Amniocenteza – badanie płynu owodniowego pobieranego przez nakłucie macicy, zwykle wykonywane między 15. a 20. tygodniem ciąży
- Biopsja kosmówki (CVS) – pobranie fragmentu trofoblastu, wykonywane między 10. a 13. tygodniem ciąży
Wyniki tych badań prenatalnych mogą z wysokim stopniem pewności stwierdzić, czy płód ma mukowiscydozę lub jest nosicielem mutacji genu CFTR.1
Wyzwania w diagnostyce mukowiscydozy
Ograniczenia badań przesiewowych
Mimo że badania przesiewowe noworodków znacząco poprawiły wczesną diagnozę mukowiscydozy, mają one pewne ograniczenia. Około 5% przypadków mukowiscydozy może nie zostać wykrytych w badaniu przesiewowym.12
Badania wykazały, że badania przesiewowe są najbardziej skuteczne w wykrywaniu mukowiscydozy u osób pochodzenia europejskiego (białych), podczas gdy u osób innych ras czułość badań jest niższa. Według jednego z badań, typowe panele badań przesiewowych mogą przeoczyć około 44% przypadków mukowiscydozy u dzieci azjatyckich, 22% u dzieci czarnoskórych i 14% u dzieci pochodzenia latynoskiego, rdzennie amerykańskiego i rdzennych mieszkańców Alaski.12
Różnicowanie diagnostyczne
Objawy mukowiscydozy mogą przypominać inne choroby układu oddechowego, takie jak astma czy przewlekłe zapalenie oskrzeli, co może prowadzić do opóźnienia właściwej diagnozy, szczególnie u pacjentów z łagodniejszymi postaciami choroby.12
Znaczenie wczesnej diagnozy
Wczesna diagnoza mukowiscydozy ma kluczowe znaczenie dla dalszego przebiegu choroby. Umożliwia szybkie rozpoczęcie leczenia, co prowadzi do poprawy funkcji płuc, stanu odżywienia oraz zapobiega lub opóźnia wystąpienie powikłań.12
Opóźnienie diagnozy wiąże się z gorszym stanem zdrowia, szczególnie w zakresie funkcji płuc i stanu odżywienia. Dzieci z opóźnioną diagnozą mają zwiększone ryzyko rozwoju ciężkiej choroby płuc i niedożywienia.12
| Metoda diagnostyczna | Zastosowanie | Interpretacja wyników |
|---|---|---|
| Test chlorkowy potu | Złoty standard w diagnostyce mukowiscydozy | ≥ 60 mmol/L – diagnoza mukowiscydozy 30-59 mmol/L – wynik niejednoznaczny < 30 mmol/L – mukowiscydoza mało prawdopodobna |
| Badanie przesiewowe noworodków (IRT) | Wstępna identyfikacja noworodków z ryzykiem mukowiscydozy | Podwyższony poziom IRT wymaga dalszych badań |
| Badania genetyczne | Identyfikacja mutacji genu CFTR | Dwie mutacje powodujące CF – diagnoza mukowiscydozy Jedna mutacja – nosicielstwo |
| Różnica potencjałów w nabłonku nosa (NPD) | Diagnostyka przypadków niejednoznacznych | Nieprawidłowy wynik potwierdza dysfunkcję CFTR |
| Pomiar prądu jelitowego (ICM) | Diagnostyka przypadków niejednoznacznych | Nieprawidłowy wynik potwierdza dysfunkcję CFTR |
| Badanie elastazy trzustkowej w kale | Ocena funkcji trzustki | Niski poziom wskazuje na niewydolność trzustki |
| Doustny test tolerancji glukozy (OGTT) | Wykrywanie cukrzycy związanej z mukowiscydozą | Nieprawidłowy wynik sugeruje CFRD |
Podsumowanie procesu diagnostycznego
Diagnoza mukowiscydozy jest procesem wieloetapowym, który zazwyczaj rozpoczyna się od badań przesiewowych noworodków, a następnie obejmuje test chlorkowy potu, badania genetyczne oraz ocenę kliniczną. Dodatkowo, w zależności od sytuacji klinicznej, stosuje się szereg badań uzupełniających, takich jak badania czynności płuc, badania obrazowe, mikrobiologiczne oraz oceniające funkcję trzustki i układu pokarmowego.12
Wczesna i precyzyjna diagnoza mukowiscydozy ma kluczowe znaczenie dla dalszego przebiegu choroby, umożliwiając wdrożenie odpowiedniego leczenia, które może znacząco poprawić jakość i długość życia pacjentów. Dlatego istotne jest, aby w przypadku pozytywnego wyniku badania przesiewowego lub objawów sugerujących mukowiscydozę, pacjent został skierowany do specjalistycznego ośrodka zajmującego się leczeniem mukowiscydozy w celu przeprowadzenia pełnej diagnostyki.123
Kolejne rozdziały
Zapraszamy do dalszego czytania naszego leksykonu.
Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.
Materiały źródłowe
- #1 Cystic Fibrosis – Diagnosis | NHLBI, NIHhttps://www.nhlbi.nih.gov/health/cystic-fibrosis/diagnosis
Diagnosing cystic fibrosis takes several steps. Your healthcare provider may diagnose cystic fibrosis based on your symptoms and the results of genetic and sweat chloride tests. […] It is important to diagnose cystic fibrosis as early as possible. Newborn screening makes it possible to detect the disease early in life. Early treatment helps prevent complications and can improve survival. […] Newborn screening for cystic fibrosis is performed during a baby’s first two to three days of life. A few drops of blood from a heel prick are placed on a special card and tested by a lab. […] If IRT is high, then the hospital will likely test the baby’s DNA for some of the CFTR mutations that cause cystic fibrosis. […] After a positive or unclear screening test result, the diagnosis should be confirmed with further testing.
- #1 Cystic fibrosis – Diagnosis and treatment – Mayo Clinichttps://www.mayoclinic.org/diseases-conditions/cystic-fibrosis/diagnosis-treatment/drc-20353706
To diagnose cystic fibrosis, healthcare professionals typically do a physical exam, review your symptoms and do tests. […] Every state in the U.S. now routinely screens newborns for cystic fibrosis. Early diagnosis means that treatment can begin right away. Testing can include: […] In this screening test, a healthcare professional takes a few drops of blood from the baby’s heel. A lab checks the blood sample for higher levels than expected of a chemical called immunoreactive trypsinogen (IRT). IRT is released by the pancreas and may suggest CF. […] To check if a baby has CF, a sweat test is done once the baby is at least 2 weeks old. A chemical that causes the skin to sweat is put on a small area of skin. Then the sweat is collected to test it and see if it’s saltier than typical. Testing done at a care center accredited by the Cystic Fibrosis Foundation helps ensure results that can be trusted.
- #1 Diagnostic Testing – Johns Hopkins Cystic Fibrosis Centerhttps://hopkinscf.org/knowledge/diagnostic-testing/
Sweat testing is the gold standard for the diagnosis of cystic fibrosis. […] The sweat test is considered the gold standard for the diagnosis of CF. […] Any positive newborn screening test must be followed by sweat testing, which remains the gold standard for diagnosis of CF. […] A sweat chloride concentration of 60 mmol/L or greater is indicative of cystic fibrosis. […] Elevated chloride levels in the sweat can be used to diagnose CF. […] Most people with CF can be diagnosed with commercially available CFTR gene mutation screening panels, which test for the most common CFTR gene mutations. […] Clinical features of the individual as well as sweat test and mutation analysis results must be taken into consideration when interpreting the NPD to diagnose CF.
- #1 Diagnosis of Cystic Fibrosis – Stanford Medicine Children’s Healthhttps://www.stanfordchildrens.org/en/topic/default?id=diagnosis-of-cystic-fibrosis-90-P02931
Newborns are screened for cystic fibrosis (CF) as part of each state’s newborn screening program. If the results are positive, it does not mean your baby has cystic fibrosis. More tests are done as described below. […] In addition to a full health history and physical exam, other tests for CF may include: […] Sweat (chloride) test. This test measures the amount of chloride in the sweat. It’s done by placing a solution on the forearm (or the thigh, if your child is too small) and attaching electrodes. The skin is stimulated to sweat with a mild electric current. This does not cause pain or harm your child. The sweat is collected onto a gauze pad and checked. Higher than normal amounts of chloride may suggest CF. The sweat test is not painful. It often causes only minor discomfort. […] Genetic tests. Blood, or cells taken from a cheek scraping, can be tested for mutations in the CFTR gene.
- #1 Cystic Fibrosis – Diagnosis | NHLBI, NIHhttps://www.nhlbi.nih.gov/health/cystic-fibrosis/diagnosis
A sweat test checks for high levels of chloride in your sweat. The sweat test is the standard test for diagnosing cystic fibrosis. […] A chloride level of 60 millimoles per liter (mmol/L) or greater indicates cystic fibrosis. A chloride level of 30 to 59 mmol/L indicates that a diagnosis of cystic fibrosis is unclear and that further testing is needed. A chloride level of less than 30 mmol/L indicates that a diagnosis of cystic fibrosis is unlikely.
- #1 Diagnosis and Treatment | trudellmed.comhttps://www.trudellmed.com/global/en/living-cystic-fibrosis/diagnosis-treatment
A cystic fibrosis sweat test (also known as a sweat chloride test) is used to diagnose CF in infants, children and adults. In the test a small amount of sweat is collected from the surface of your skin and the chloride or salt content is measured. People with CF may have very salty sweat. For a person who has CF, the sweat test results typically confirm the diagnosis by showing a high chloride level. […] Genetic testing is used to determine the exact gene mutation. More than 2,000 different CFTR gene mutations have been identified. One of the most common is the delta F508 mutation. The specific mutations and combination of genes you have is known as your genotype. Your genotype will dictate the symptoms you have and the treatments you take. […] In children who are not diagnosed by newborn screening, most are diagnosed with cystic fibrosis once they start to show symptoms. Common symptoms in children include chronic coughing, not gaining weight as well as expected, and abnormal bowel movements.
- #1 Cystic fibrosis – Diagnosis and treatment – Mayo Clinichttps://www.mayoclinic.org/diseases-conditions/cystic-fibrosis/diagnosis-treatment/drc-20353706
Healthcare professionals also may recommend genetic testing to look for specific changes on the gene responsible for CF. Genetic testing may be used along with IRT levels to confirm the diagnosis. […] Cystic fibrosis tests may be recommended for older children and adults who weren’t screened at birth. Your healthcare professional may suggest genetic and sweat tests for CF if you have repeated bouts of an inflamed pancreas, nasal polyps, chronic sinus infections, lung infections, bronchiectasis or male infertility.
- #1 Cystic Fibrosis: Prenatal Screening and Diagnosis | ACOGhttps://www.acog.org/womens-health/faqs/cystic-fibrosis-prenatal-screening-and-diagnosis
Cystic fibrosis (CF) is a lifelong illness that can affect all of the organs of the body. […] Carrier screening allows parents-to-be to find out their chances of having a child with CF. If you are already pregnant, a prenatal diagnostic test allows you to find out if your fetus actually has CF or is a carrier. […] Testing can be done to learn if a fetus has CF or is a carrier. This is called prenatal diagnostic testing. This testing can be done as early as 10 weeks of pregnancy. […] Prenatal diagnostic tests to detect CF and other disorders include amniocentesis and chorionic villus sampling (CVS). […] The results of these prenatal tests can tell you with a high degree of certainty whether the fetus has CF or is a CF carrier.
- #1 Cystic fibrosis – Symptoms and causes – Mayo Clinichttps://www.mayoclinic.org/diseases-conditions/cystic-fibrosis/symptoms-causes/syc-20353700
In the U.S., because of newborn screening, cystic fibrosis can be diagnosed within the first month of life, before symptoms develop. […] People who are not diagnosed until adulthood usually have milder symptoms and are more likely to have symptoms that aren’t typical. These may include repeated bouts of an inflamed pancreas called pancreatitis, infertility and repeated bouts of pneumonia. […] If you’re a person of color and have symptoms that could be CF, talk to your healthcare professional so that you can get tested for CF.
- #1 Common Medical Tests for Cystic Fibrosis Diagnosis and Monitoringhttps://www.rwjbh.org/rwj-university-hospital-new-brunswick/treatment-care/pulmonary-medicine-and-critical-care/cystic-fibrosis-center/diagnosis-and-monitoring/
The Cystic Fibrosis (CF) Center provides outpatient testing and services to pediatric, adolescent, and adult patients with CF. Below are some of the tests used to diagnose and monitor the disease. […] The sweat test has been the gold standard for diagnosing cystic fibrosis (CF) for more than 40 years. […] In addition to the sweat test, genetic testing for CF is now standard and recommended. […] The fecal elastase test is a stool test that can determine the level of pancreatic function. […] Bloodwork enables physicians to check blood counts, electrolytes, liver function, clotting times, fat soluble vitamin levels, glucose tolerance, liver function, lipid panel, and immunoglobulins. […] A sputum culture enables doctors to see what bacteria you may have and what antibiotics can be effective in fighting it.
- #1 Diagnosis of Cystic Fibrosis – Stanford Medicine Children’s Healthhttps://www.stanfordchildrens.org/en/topic/default?id=diagnosis-of-cystic-fibrosis-90-P02931
Your child may also have these tests: […] Blood tests. These may include pancreatic function tests. […] Chest X-rays. This test uses invisible electromagnetic energy beams to makes images of internal tissues, bones, and organs onto film. […] Pulmonary function tests. These tests help measure the lungs’ ability to exchange oxygen and carbon dioxide correctly. They are often done with special machines that a child must breathe into. […] Sputum cultures. This test is done on the material that is coughed up from the lungs and into the mouth. A sputum culture is often done to find out if an infection is present. […] Stool evaluations. These are done to measure the amount of fat in a stool sample. Too much fat may mean the digestive system is not working correctly.
- #1 Cystic Fibrosis – Diagnosis and Treatmenthttps://www.radiologyinfo.org/en/info/cysticfibrosis
To diagnose cystic fibrosis, doctors usually perform blood tests. […] They may test sweat for high salt content, which can indicate cystic fibrosis. […] To diagnosis cystic fibrosis, doctors take a blood sample for genetic testing or conduct a sweat test. A sweat test measures the amount of salt in a person’s sweat. High salt in the sweat can indicate cystic fibrosis. […] The United States now requires screening of newborns for cystic fibrosis through testing blood samples. […] Doctors may use a stool test, spirometry, or sputum culture to evaluate cystic fibrosis. […] They may also order the following imaging tests: […] Chest or abdominal computed tomography (CT) scan: These exams use special x-ray equipment and computers to produce detailed images of the inside of the lungs or intestines.
- #1 Common Medical Tests for Cystic Fibrosis Diagnosis and Monitoringhttps://www.rwjbh.org/rwj-university-hospital-new-brunswick/treatment-care/pulmonary-medicine-and-critical-care/cystic-fibrosis-center/diagnosis-and-monitoring/
Starting at age 10, patients should have an oral glucose tolerance test (OGTT) once annually to screen for CF-related diabetes (CFRD). […] A chest X-ray is recommended annually to monitor for disease progression or any abnormalities in the lungs that should be treated. […] Pulmonary function tests (PFT) are tests that measure how well your lungs are working. […] The Cystic Fibrosis Foundation recommends that people with CF have following tests every year: Bloodwork, Bone mineral density scan, Full pulmonary function testing, Imaging, Oral glucose tolerance test (for non-diabetic patients 10 years and up).
- #1 The diagnosis of cystic fibrosis – PubMedhttps://pubmed.ncbi.nlm.nih.gov/28576637/
Establishing the diagnosis of cystic fibrosis (CF) is straight forward in the majority of patients: they present with a clear clinical picture (most frequently chronic respiratory symptoms plus malabsorption), the sweat chloride value is60mmol/L and two known disease causing CFTR mutations are identified. […] In less than 5% of subjects, mainly those with a milder or limited phenotype, the diagnostic process is more complex, because initial diagnostic test results are inconclusive: sweat chloride concentration in the intermediate range, less than 2 CF causing mutations identified or both. […] These patients should be referred to expert centers where bioassays of CFTR function like nasal potential difference measurement or intestinal current measurement can be done. […] Still, in some patients, despite symptoms compatible with CF and some indication of CFTR dysfunction (e.g. only intermediate sweat chloride value), diagnostic criteria are not met (e.g. only 1 CFTR mutation identified).
- #1 Cystic Fibrosis: Causes, Symptoms & Treatmenthttps://my.clevelandclinic.org/health/diseases/9358-cystic-fibrosis
The sweat test measures the amount of chloride in your bodys sweat. Chloride levels in sweat are higher in people who have CF. This is the most conclusive test for CF, but it may be normal in people with atypical CF. […] A provider tests blood samples for changes in the genes that cause CF. […] Providers use imaging, like sinus and chest X-rays, to support or confirm a CF diagnosis. Imaging alone cant diagnose CF. […] Your healthcare provider takes a sample of your sputum (mucus coughed up from your lungs) and tests it for bacteria. Certain bacteria, such as Pseudomonas, are most commonly found in people who have CF. […] This can tell your provider if you have cysts or damage to your pancreas. […] This test measures the small amount of electrical charge thats usually present in the lining of your nose. The movement of ions creates this charge. People with CF dont have as much ion movement because of the way CF affects their ion channels. […] A provider takes a sample of rectal tissue to perform this test. A lab uses the sample to measure how much chloride it secretes.
- #1 CF Diagnosis Clinical Care Guidelines | Cystic Fibrosis Foundationhttps://www.cff.org/medical-professionals/cf-diagnosis-clinical-care-guidelines
To help standardize the diagnosis of both infants with positive newborn screening results and older patients with what may be cystic fibrosis symptoms, the Cystic Fibrosis Foundation worked with CF medical experts to develop guidelines on the steps leading to a confirmed diagnosis. […] The diagnosis of cystic fibrosis is based on clinical signs and symptoms consistent with the disease and objective evidence of cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction. […] The Cystic Fibrosis Foundation assembled a group of 32 CF diagnosis experts from 10 countries to revise prior diagnostic criteria. […] The discussion generated specific consensus statements voted on by conference participants. The statements that met the threshold of 80 percent agreement were enacted. […] The diagnosis of cystic fibrosis is based on clinical signs and symptoms consistent with the disease and objective evidence of cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction.
- #1 Cystic Fibrosis | Choose the Right Testhttps://arupconsult.com/content/cystic-fibrosis
The identification of two severe pathogenic CFTR variants on opposite chromosomes is also diagnostic for CF; however, the absence of a positive genetic result does not exclude CF. […] Molecular testing for CF is indicated for the following – : Carrier screening in individuals who are pregnant or planning a pregnancy, Carrier screening in individuals with a family history of CF or CFTR-related conditions, Diagnosis in newborns with a positive newborn screening result, Diagnosis in adult or pediatric patients with signs or symptoms or a family history of CF, Confirmation of the causative CFTR gene variants in a known affected individual to determine eligibility for CFTR variant-specific treatment. […] The Cystic Fibrosis Foundation proposes the following diagnostic criteria for CF in an individual with a positive newborn screening test, signs and/or symptoms of CF, or a family history of CF: A positive sweat chloride test result 60 mmol/L, Identification of two CF-causing variants on separate chromosomes and a sweat chloride value of 30 mmol/L, Demonstrated CFTR dysfunction (ie, a sweat chloride test result of 60 mmol/L or CF-typical nasal potential difference or intestinal current measurement), regardless of whether or not two molecular pathogenic variants can be identified.
- #1 CF Diagnosis Clinical Care Guidelines | Cystic Fibrosis Foundationhttps://www.cff.org/medical-professionals/cf-diagnosis-clinical-care-guidelines
In the U.S., these asymptomatic newborns were described as having CFTR-related metabolic syndrome (CRMS), whereas a European-led advisory group used the term CF Screen Positive, Inconclusive Diagnosis (CFSPID). […] The Cystic Fibrosis Foundation assembled a group of 32 CF diagnosis experts from 10 countries to revise prior diagnostic criteria with specific attention to the above challenges. […] The results were published as six articles in a supplementary issue of the Journal of Pediatrics. […] For individuals presenting with CF symptoms, the same diagnostic criteria recommended for the screened population for sweat chloride testing, CFTR genetic analysis, and CFTR functional testing should be used to confirm a CF diagnosis. […] The diagnosis of CFTR-related disorder has been defined as a monosymptomatic clinical entity (CBAVD/pancreatitis/bronchiectasis) associated with CFTR dysfunction that does not fulfill the diagnostic criteria for CF. […] The absence of detection of two CF-causing CFTR mutations does not exclude a diagnosis of CF.
- #1 The diagnosis of cystic fibrosis – PubMedhttps://pubmed.ncbi.nlm.nih.gov/28576637/
For these subjects, the term CFTR related disorder (CFTR-RD) is used. […] In many countries, nationwide CF newborn screening (NBS) has been introduced. […] In screen positive babies, the diagnosis of CF must be confirmed by a sweat test demonstrating a sweat chloride concentration above 60mmol/L. […] To achieve the benefit of NBS, every baby in whom the diagnosis of CF is confirmed must receive immediate follow-up and treatment in a CF reference center. […] CF NBS is not full proof: some diagnoses will be missed and in some babies the diagnosis cannot be confirmed nor ruled out with certainty. […] Even in 2016, the most reliable and widely available diagnostic test for CF is the measurement of chloride concentration in sweat. […] The method of choice is sweat induction by pilocarpine iontophoresis, followed by sweat collection on a gauze or filter paper or in a Macroduct coil. […] Since mutation specific therapies have become available, it is important to identify the mutations responsible for CF in each individual patient.
- #1 For Some Families of Color, a Painful Fight for a Cystic Fibrosis Diagnosis – The New York Timeshttps://www.nytimes.com/2024/05/29/well/live/cystic-fibrosis-screening.html
Jahsir was diagnosed with cystic fibrosis at 3 months old. […] Cystic fibrosis is a progressive disease caused by defects in a single gene. […] Universal screening has helped doctors diagnose babies an average of three months sooner, said Dr. Clement Ren, the director of the Cystic Fibrosis Center at Childrenâs Hospital of Philadelphia. […] The screening process starts before newborns leave the hospital, with a blood test for a protein that is commonly elevated in babies with cystic fibrosis. […] One study examined nine screening panels commonly used across the United States and found that although they accurately identified an estimated 95 percent of white babies with cystic fibrosis, they missed, on average, 44 percent of Asian babies, 22 percent of Black infants and 14 percent of Hispanic, Native American and Alaskan Native babies.
- #1 Diagnosis – Cystic Fibrosis Australiahttps://www.cysticfibrosis.org.au/diagnosis/
Since 1986, all newborns in Australia, have been subject to a heel prick test. This test is used to screen for a number of conditions, one of which is an indicator for cystic fibrosis (CF). […] The heel prick test does not detect everyone and a sweat test may be required, as high levels of salt in perspiration is extremely common amongst those with CF. […] Diagnosis may also result after a baby is born with obvious CF symptoms such as a bowel blockage or failure to thrive. […] Occasionally CF may not be diagnosed until later in life. Some children are diagnosed later in childhood, whether it be weeks after birth or even years, and sometimes CF is not diagnosed until adulthood. […] One reason for this is that CF can vary widely in its severity and symptoms, and can resemble other lung conditions such as asthma or bronchitis which makes diagnosis challenging. Another reason is that there are around 2,000 different gene changes that cause CF and some genes have been identified after a person has had their newborn heel prick test, or the gene they have is harder to detect.
- #1 Diagnosis of Cystic Fibrosis Often Missed or Delayed, Especially in Non-White Infants | Lurie Children’shttps://www.luriechildrens.org/en/news-stories/diagnosis-of-cystic-fibrosis-often-missed-or-delayed-especially-in-non-white-infants/
Newborn screening tests also can yield false-negative results, particularly in non-White infants, which is important for physicians to recognize. […] Even when the screening test is negative, babies with symptoms of cystic fibrosis within the first month of life, such as meconium ileus (a type of bowel obstruction) or poor growth, must be referred for evaluation immediately. […] Among non-White populations, Black and Asian children experience the highest rate of false-negative newborn screening results or delayed diagnosis of cystic fibrosis. […] This can delay diagnostic evaluation, said Dr. McColley. […] Delays in evaluation and initiation of treatment are associated with more lung disease during the first year of life and poorer growth that persists through early childhood. […] We provide actionable data to improve timeliness and equity in the diagnosis and treatment of cystic fibrosis through newborn screening, said Dr. McColley.
- #1 Testing for CF | Cystic Fibrosis Foundationhttps://www.cff.org/intro-cf/testing-cf
Diagnosing CF is a multistep process. A complete diagnostic evaluation should include a newborn screening, a sweat chloride test, a genetic or carrier test, and a clinical evaluation at a CF Foundation-accredited care center. […] Carrier (or genetic) testing not only plays a key role in the diagnosis of cystic fibrosis, but testing also allows parents to find out what their chances are of having a child with CF to help inform important family planning decisions. […] Newborn screening (NBS) is a program run by each state to identify babies born with certain health conditions, including cystic fibrosis. Although a sweat test should ultimately be done to rule out or confirm a CF diagnosis, NBS can help you and your health care providers take immediate steps to keep your child as healthy as possible.
- #2 The diagnosis of cystic fibrosis – PubMedhttps://pubmed.ncbi.nlm.nih.gov/28576637/
Establishing the diagnosis of cystic fibrosis (CF) is straight forward in the majority of patients: they present with a clear clinical picture (most frequently chronic respiratory symptoms plus malabsorption), the sweat chloride value is60mmol/L and two known disease causing CFTR mutations are identified. […] In less than 5% of subjects, mainly those with a milder or limited phenotype, the diagnostic process is more complex, because initial diagnostic test results are inconclusive: sweat chloride concentration in the intermediate range, less than 2 CF causing mutations identified or both. […] These patients should be referred to expert centers where bioassays of CFTR function like nasal potential difference measurement or intestinal current measurement can be done. […] Still, in some patients, despite symptoms compatible with CF and some indication of CFTR dysfunction (e.g. only intermediate sweat chloride value), diagnostic criteria are not met (e.g. only 1 CFTR mutation identified).
- #2 Cystic fibrosis – Diagnosis and treatment – Mayo Clinichttps://www.mayoclinic.org/diseases-conditions/cystic-fibrosis/diagnosis-treatment/drc-20353706
To diagnose cystic fibrosis, healthcare professionals typically do a physical exam, review your symptoms and do tests. […] Every state in the U.S. now routinely screens newborns for cystic fibrosis. Early diagnosis means that treatment can begin right away. Testing can include: […] In this screening test, a healthcare professional takes a few drops of blood from the baby’s heel. A lab checks the blood sample for higher levels than expected of a chemical called immunoreactive trypsinogen (IRT). IRT is released by the pancreas and may suggest CF. […] To check if a baby has CF, a sweat test is done once the baby is at least 2 weeks old. A chemical that causes the skin to sweat is put on a small area of skin. Then the sweat is collected to test it and see if it’s saltier than typical. Testing done at a care center accredited by the Cystic Fibrosis Foundation helps ensure results that can be trusted.
- #2 Cystic Fibrosis: Causes, Symptoms & Treatmenthttps://my.clevelandclinic.org/health/diseases/9358-cystic-fibrosis
Healthcare providers often test for cystic fibrosis during a newborn screening. Providers perform this test with a few drops of blood from your babys heel. A lab looks in the blood sample for immunoreactive trypsinogen (IRT), a chemical made in your pancreas. People with CF have higher levels of IRT in their blood. Babies are often tested for IRT shortly after birth and a few weeks later. […] If your baby has higher levels of IRT than expected, your healthcare provider will order additional tests to make a final diagnosis. […] In about 5% of cases, the newborn screen doesnt detect elevated IRT levels in someone with CF. Or you may have been born before routine CF screening was available. If you or your child has symptoms of CF, a provider will perform a sweat test and follow up with additional tests as needed.
- #2 Testing for CF | Cystic Fibrosis Foundationhttps://www.cff.org/intro-cf/testing-cf
Diagnosing CF is a multistep process. A complete diagnostic evaluation should include a newborn screening, a sweat chloride test, a genetic or carrier test, and a clinical evaluation at a CF Foundation-accredited care center. […] Carrier (or genetic) testing not only plays a key role in the diagnosis of cystic fibrosis, but testing also allows parents to find out what their chances are of having a child with CF to help inform important family planning decisions. […] Newborn screening (NBS) is a program run by each state to identify babies born with certain health conditions, including cystic fibrosis. Although a sweat test should ultimately be done to rule out or confirm a CF diagnosis, NBS can help you and your health care providers take immediate steps to keep your child as healthy as possible.
- #2 The diagnosis of cystic fibrosis – PubMedhttps://pubmed.ncbi.nlm.nih.gov/28576637/
For these subjects, the term CFTR related disorder (CFTR-RD) is used. […] In many countries, nationwide CF newborn screening (NBS) has been introduced. […] In screen positive babies, the diagnosis of CF must be confirmed by a sweat test demonstrating a sweat chloride concentration above 60mmol/L. […] To achieve the benefit of NBS, every baby in whom the diagnosis of CF is confirmed must receive immediate follow-up and treatment in a CF reference center. […] CF NBS is not full proof: some diagnoses will be missed and in some babies the diagnosis cannot be confirmed nor ruled out with certainty. […] Even in 2016, the most reliable and widely available diagnostic test for CF is the measurement of chloride concentration in sweat. […] The method of choice is sweat induction by pilocarpine iontophoresis, followed by sweat collection on a gauze or filter paper or in a Macroduct coil. […] Since mutation specific therapies have become available, it is important to identify the mutations responsible for CF in each individual patient.
- #2 Cystic Fibrosis Diagnosis | Norton Children’s Louisville, Ky.https://nortonchildrens.com/services/pediatric-pulmonologist/programs/cystic-fibrosis/cystic-fibrosis-diagnosis/
What Do Sweat Test Scores Mean? […] A sweat chloride value of 60 millimoles per liter or higher is consistent with CF. A value between 30 and 59 millimoles per liter is inconclusive and may require further testing. A value less than 30 millimoles per liter is considered normal. […] Can You Test for CF While Pregnant? […] CF can be diagnosed in an unborn baby during pregnancy using one of two tests: […] The American College of Obstetricians and Gynecologists recommends that all people who are considering pregnancy or are currently pregnant be offered a CF gene carrier screening. […] Can Parents be Tested to See if They are CF Gene Carriers? […] Adults planning to have children can be tested to determine if they are carriers for the condition. Genetic counseling is available for parents who are found to be carriers.
- #2 Diagnostic Testing – Johns Hopkins Cystic Fibrosis Centerhttps://hopkinscf.org/knowledge/diagnostic-testing/
Sweat testing is the gold standard for the diagnosis of cystic fibrosis. […] The sweat test is considered the gold standard for the diagnosis of CF. […] Any positive newborn screening test must be followed by sweat testing, which remains the gold standard for diagnosis of CF. […] A sweat chloride concentration of 60 mmol/L or greater is indicative of cystic fibrosis. […] Elevated chloride levels in the sweat can be used to diagnose CF. […] Most people with CF can be diagnosed with commercially available CFTR gene mutation screening panels, which test for the most common CFTR gene mutations. […] Clinical features of the individual as well as sweat test and mutation analysis results must be taken into consideration when interpreting the NPD to diagnose CF.
- #2 CF Diagnosis Clinical Care Guidelines | Cystic Fibrosis Foundationhttps://www.cff.org/medical-professionals/cf-diagnosis-clinical-care-guidelines
In the U.S., these asymptomatic newborns were described as having CFTR-related metabolic syndrome (CRMS), whereas a European-led advisory group used the term CF Screen Positive, Inconclusive Diagnosis (CFSPID). […] The Cystic Fibrosis Foundation assembled a group of 32 CF diagnosis experts from 10 countries to revise prior diagnostic criteria with specific attention to the above challenges. […] The results were published as six articles in a supplementary issue of the Journal of Pediatrics. […] For individuals presenting with CF symptoms, the same diagnostic criteria recommended for the screened population for sweat chloride testing, CFTR genetic analysis, and CFTR functional testing should be used to confirm a CF diagnosis. […] The diagnosis of CFTR-related disorder has been defined as a monosymptomatic clinical entity (CBAVD/pancreatitis/bronchiectasis) associated with CFTR dysfunction that does not fulfill the diagnostic criteria for CF. […] The absence of detection of two CF-causing CFTR mutations does not exclude a diagnosis of CF.
- #2 Cystic Fibrosis | Choose the Right Testhttps://arupconsult.com/content/cystic-fibrosis
The identification of two severe pathogenic CFTR variants on opposite chromosomes is also diagnostic for CF; however, the absence of a positive genetic result does not exclude CF. […] Molecular testing for CF is indicated for the following – : Carrier screening in individuals who are pregnant or planning a pregnancy, Carrier screening in individuals with a family history of CF or CFTR-related conditions, Diagnosis in newborns with a positive newborn screening result, Diagnosis in adult or pediatric patients with signs or symptoms or a family history of CF, Confirmation of the causative CFTR gene variants in a known affected individual to determine eligibility for CFTR variant-specific treatment. […] The Cystic Fibrosis Foundation proposes the following diagnostic criteria for CF in an individual with a positive newborn screening test, signs and/or symptoms of CF, or a family history of CF: A positive sweat chloride test result 60 mmol/L, Identification of two CF-causing variants on separate chromosomes and a sweat chloride value of 30 mmol/L, Demonstrated CFTR dysfunction (ie, a sweat chloride test result of 60 mmol/L or CF-typical nasal potential difference or intestinal current measurement), regardless of whether or not two molecular pathogenic variants can be identified.
- #2 Cystic Fibrosis (CF) Diagnosis | National Jewish Healthhttps://www.nationaljewish.org/conditions/cf/diagnosis
Children are most often diagnosed with cystic fibrosis through newborn screening tests. […] Newborn screening for cystic fibrosis is now required in all 50 states and the District of Columbia. […] Many studies have proven that CF diagnosed early in life results in healthier children and increased survival rates when compared to children with a delayed diagnosis. […] The United States Centers for Disease Control and Prevention (CDC) and the Cystic Fibrosis Foundation recommend newborn screening. […] Newborn screening is not a definitive diagnostic test for cystic fibrosis. If the test is positive, a sweat test and genetic testing may be done. […] Most adult diagnoses are made after symptoms are present. […] Mild forms of CF can remain undiagnosed until adulthood. […] Reliable testing is one of the most significant advances in our understanding and treatment of CF. Testing is important for children and adults suspected of having the disease.
- #2 New Diagnosishttps://cysticfibrosis.ca/new-diagnosis
Most adult diagnoses are made when an individual exhibits one or more symptoms typical of CF. Once an individual begins to exhibit these symptoms, a sweat test will be ordered, and if positive generally will be followed by genetic testing for CFTR mutations. […] The key diagnostic tool is a sweat test. […] An important first step is to learn about cystic fibrosis and what is involved in managing your symptoms.
- #2 Common Medical Tests for Cystic Fibrosis Diagnosis and Monitoringhttps://www.rwjbh.org/rwj-university-hospital-new-brunswick/treatment-care/pulmonary-medicine-and-critical-care/cystic-fibrosis-center/diagnosis-and-monitoring/
Starting at age 10, patients should have an oral glucose tolerance test (OGTT) once annually to screen for CF-related diabetes (CFRD). […] A chest X-ray is recommended annually to monitor for disease progression or any abnormalities in the lungs that should be treated. […] Pulmonary function tests (PFT) are tests that measure how well your lungs are working. […] The Cystic Fibrosis Foundation recommends that people with CF have following tests every year: Bloodwork, Bone mineral density scan, Full pulmonary function testing, Imaging, Oral glucose tolerance test (for non-diabetic patients 10 years and up).
- #2 Cystic Fibrosis – Diagnosis and Treatmenthttps://www.radiologyinfo.org/en/info/cysticfibrosis
Chest x-ray: This exam uses a small dose of ionizing radiation to produce images to evaluate for dilated airways filled with mucus and to evaluate lung infections that need to be treated with antibiotics. […] Chest or abdominal magnetic resonance imaging (MRI): These exams use a powerful magnet, radio waves and a computer to produce detailed pictures of the lungs and digestive tract. […] Abdominal ultrasound: This imaging test uses a small probe, gel, and sound waves to produce pictures of the upper abdomen. […] CT of the sinuses: This exam combines special x-ray equipment and a computer to produce multiple images of the paranasal sinus cavities.
- #2 Diagnosis of Cystic Fibrosis – Stanford Medicine Children’s Healthhttps://www.stanfordchildrens.org/en/topic/default?id=diagnosis-of-cystic-fibrosis-90-P02931
Your child may also have these tests: […] Blood tests. These may include pancreatic function tests. […] Chest X-rays. This test uses invisible electromagnetic energy beams to makes images of internal tissues, bones, and organs onto film. […] Pulmonary function tests. These tests help measure the lungs’ ability to exchange oxygen and carbon dioxide correctly. They are often done with special machines that a child must breathe into. […] Sputum cultures. This test is done on the material that is coughed up from the lungs and into the mouth. A sputum culture is often done to find out if an infection is present. […] Stool evaluations. These are done to measure the amount of fat in a stool sample. Too much fat may mean the digestive system is not working correctly.
- #2 Common Medical Tests for Cystic Fibrosis Diagnosis and Monitoringhttps://www.rwjbh.org/rwj-university-hospital-new-brunswick/treatment-care/pulmonary-medicine-and-critical-care/cystic-fibrosis-center/diagnosis-and-monitoring/
The Cystic Fibrosis (CF) Center provides outpatient testing and services to pediatric, adolescent, and adult patients with CF. Below are some of the tests used to diagnose and monitor the disease. […] The sweat test has been the gold standard for diagnosing cystic fibrosis (CF) for more than 40 years. […] In addition to the sweat test, genetic testing for CF is now standard and recommended. […] The fecal elastase test is a stool test that can determine the level of pancreatic function. […] Bloodwork enables physicians to check blood counts, electrolytes, liver function, clotting times, fat soluble vitamin levels, glucose tolerance, liver function, lipid panel, and immunoglobulins. […] A sputum culture enables doctors to see what bacteria you may have and what antibiotics can be effective in fighting it.
- #2 Cystic Fibrosis: Causes, Symptoms & Treatmenthttps://my.clevelandclinic.org/health/diseases/9358-cystic-fibrosis
The sweat test measures the amount of chloride in your bodys sweat. Chloride levels in sweat are higher in people who have CF. This is the most conclusive test for CF, but it may be normal in people with atypical CF. […] A provider tests blood samples for changes in the genes that cause CF. […] Providers use imaging, like sinus and chest X-rays, to support or confirm a CF diagnosis. Imaging alone cant diagnose CF. […] Your healthcare provider takes a sample of your sputum (mucus coughed up from your lungs) and tests it for bacteria. Certain bacteria, such as Pseudomonas, are most commonly found in people who have CF. […] This can tell your provider if you have cysts or damage to your pancreas. […] This test measures the small amount of electrical charge thats usually present in the lining of your nose. The movement of ions creates this charge. People with CF dont have as much ion movement because of the way CF affects their ion channels. […] A provider takes a sample of rectal tissue to perform this test. A lab uses the sample to measure how much chloride it secretes.
- #2 CFF Diagnosis of Cystic Fibrosis Guideline Summaryhttps://www.guidelinecentral.com/guideline/25047/
Sweat chloride testing should be performed according to approved procedural guidelines published in established, international protocols such as the CLSI 2009 Guidelines. […] Newborns with a positive CF newborn screen, to increase the likelihood of collecting an adequate sweat specimen, should have the test performed bilaterally and when the infant weighs 2 kg, and is at least 36 wk of corrected gestational age. […] In individuals presenting with a positive newborn screen, clinical features consistent with CF, or a positive family history, a diagnosis of CF can be made if the sweat chloride value is 60 mmol/L. […] Individuals who are screen-positive and meet sweat chloride criteria for CF diagnosis should undergo CFTR genetic testing if the CFTR genotype was not available through the screening process or is incomplete.
- #2 CFF Diagnosis of Cystic Fibrosis Guideline Summaryhttps://www.guidelinecentral.com/guideline/25047/
In individuals with a positive newborn screen, a sweat chloride 30 mmol/L indicates that CF is unlikely. […] Individuals with clinical features that may be consistent with CF who have a sweat chloride 30 mmol/L indicates that CF is less likely. […] Individuals presenting with a positive newborn screen, symptoms of CF, or a positive family history, and sweat chloride values in the intermediate range (30-59 mmol/L) on two separate occasions may have CF. […] In individuals presenting with a positive newborn screen, symptoms of CF, or a positive family history, the identification of 2 CF-causing mutations (defined by CFTR2) is consistent with a diagnosis of CF. Sweat chloride testing is necessary, though, to confirm the diagnosis. […] The absence of detection of 2 CF-causing CFTR mutations does not exclude a diagnosis of CF.
- #2 CFF Diagnosis of Cystic Fibrosis Guideline Summaryhttps://www.guidelinecentral.com/guideline/25047/
In individuals with a positive newborn screen but variable or uncharacterized CFTR mutations (2 CF-causing mutations), the diagnosis of CF can be made by demonstrating CFTR dysfunction (a sweat chloride 60 mmol/L or CF-typical NPD or ICM). […] The term CRMS/CFSPID is reserved for individuals who screen positive without clinical features consistent with a diagnosis of CF. […] Children designated as CRMS/CFSPID should undergo at least one repeat sweat chloride test at CF centers with suitable expertise, such as an accredited CF center. […] The decision to reclassify children designated as CRMS/CFSPID as CF is an integrated decision that should take into account functional assessment of CFTR (sweat chloride, and possibly NPD/ICM), CFTR genetic analysis, and clinical assessment by the CF clinicians caring for the patient.
- #2 CFF Diagnosis of Cystic Fibrosis Guideline Summaryhttps://www.guidelinecentral.com/guideline/25047/
For individuals presenting with CF symptoms, the same diagnostic criteria recommended for the screened population for sweat chloride testing, CFTR genetic analysis, and CFTR functional testing should be used to confirm a CF diagnosis. […] The diagnosis of CFTR-related disorder has been defined as a monosymptomatic clinical entity (CBAVD/pancreatitis/bronchiectasis) associated with CFTR dysfunction that does not fulfill the diagnostic criteria for CF.
- #2 Cystic Fibrosis Diagnosis and Testing | Cystic Fibrosis News TodayEnvelope iconhttps://cysticfibrosisnewstoday.com/cystic-fibrosis-diagnosis/
Cystic fibrosis genetic testing involves analyzing the sequence of the CFTR gene to look for CF-causing mutations. […] The sweat test is considered the gold standard for diagnosing cystic fibrosis. […] The CF sweat test is commonly used to confirm a diagnosis after a positive result from a newborn screening. […] Prenatal screening can be done by either amniocentesis or chorionic villus sampling, known as CVS. […] The nasal potential difference, or NPD, is a test that measures the electrical potential difference â essentially, a small electrical charge â that occurs in the airway lining inside the nose. […] Other tests may be involved in diagnosing and monitoring CF. […] In the U.S., all newborns are screened for cystic fibrosis (CF) within the first few days after birth. […] It is possible to diagnose cystic fibrosis (CF) at any age.
- #2https://www.healio.com/news/pulmonology/20230807/qa-overcoming-delays-in-cystic-fibrosis-diagnosis-treatment
Black/African American and Asian infants are often diagnosed with cystic fibrosis later than white infants. […] Following newborn screening, a cystic fibrosis diagnosis is often delayed or missed in non-white infants, which can result in hospitalization and early life malnutrition, according to a Lurie Childrens Hospital press release. […] To lessen the frequency of missed diagnoses and commence cystic fibrosis (CF) treatment early, the CDCs Chronic Disease Awareness Program is funding the AChieving Equity for Disease prevention in Cystic Fibrosis (ACED-CF) campaign led by the Ann Robert H. Lurie Childrens Hospital of Chicago. […] Between 2010 and 2018, 35% of infants were diagnosed after 30 days of age, and 12.5% were diagnosed after 2 months of age. Infants who were demographically categorized as white and not Hispanic were, on average, diagnosed at 22 days, whereas infants of all other races and ethnicities were, on average, diagnosed at 31 days. Overall, 11% of diagnoses were after 180 days almost 6 months. The proportion of infants with delayed diagnosis was highest in Black/African American and Asian infants.
- #2https://www.healio.com/news/pulmonology/20230807/qa-overcoming-delays-in-cystic-fibrosis-diagnosis-treatment
Our research also showed that Black/African American and Asian infants are at the highest risk of false-negative newborn screening tests. […] The most important consequence is early life malnutrition. Although the main cause of death in people with CF is lung disease, early life nutrition predicts later lung disease and the likelihood of surviving to adulthood. […] Infants with CF who are diagnosed later (a median age of 47 days, just under 7 weeks) have decreased height for age at 5 years compared with infants who were diagnosed at a median age of 14 days. […] Screening panels should become broader. More than 700 CFTR variants are known to cause CF. […] Even with sensitive thresholds, some infant tests will be below the threshold based on a number of factors. This will cause a false-negative test even if common variants are present.
- #2 Late CF Diagnosis – Cystic Fibrosis News Today Forumshttps://cysticfibrosisnewstoday.com/forums/forums/topic/late-cf-diagnosis/
Itâs crazy to think about how many people could be living with CF and have no clue, and they are either being misdiagnosed or undiagnosed. […] I was a thin kid but ate well. As a teen, I just didnât fill out. For the past 10 years, my weight has been gradually slipping, and the number of foods that just do not agree with my entire digestive track has gone up and up. […] I wasnât diagnosed with CF until was 64 years old. […] I had scarlet fever when I was 5 years old. For years doctors told me I had chronic bronchitis, lung damage etc. It wasnât until I finally got referred to pulmonary doctor at Santa Barbara Cottage Hospital and Genetic testing results were DF508 and R117H. […] I am now on the vest with albuterol and saline nebs. […] Iâm now waiting to see if my insurance will cover Trikafta.
- #2 Diagnosis of Cystic Fibrosis Often Missed or Delayed, Especially in Non-White Infants | Lurie Children’shttps://www.luriechildrens.org/en/news-stories/diagnosis-of-cystic-fibrosis-often-missed-or-delayed-especially-in-non-white-infants/
Cystic fibrosis is a progressive genetic disease that damages multiple organs, including the lungs and pancreas. […] Advances in cystic fibrosis diagnosis and treatment have transformed its prognosis from rapid progression and childhood mortality to a chronic multisystem disease of adults with rapidly increasing life expectancy and health span. […] Newborn screening for cystic fibrosis improves nutrition and survival and has been available throughout the United States since 2010. […] It is recommended that infants who screen positive for cystic fibrosis receive their diagnostic evaluation by 28 days of age or earlier. […] Delays in diagnosis of cystic fibrosis increase the risk for severe illness, said Principal Investigator Susanna McColley, MD, pulmonologist at Lurie Childrens and Professor of Pediatrics at Northwestern University Feinberg School of Medicine.
- #2 Cystic Fibrosis: Practice Essentials, Background, Pathophysiologyhttps://emedicine.medscape.com/article/1001602-overview
Parameters for the sweat chloride test are as follows: The reference value is less than 40 mmol/L, A value higher than 60 mmol/L of chloride is consistent with CF, A value of 40-60 mmol/L is considered borderline, and the test must be repeated, In babies aged 3 months or younger, a value of 30-60 mEq/L is considered borderline and requires retesting. […] Imaging studies that may be helpful include the following: Radiography (chest, sinus, abdomen), CT of the chest (not yet advised as a routine modality in CF), Ultrasonography, Contrast barium enema. […] Additional tests that may be warranted are as follows: Genotyping, Nasal potential difference measurement, Pulmonary function testing, Bronchoalveolar lavage, Sputum microbiology, Immunoreactive trypsinogen.
- #2 CF Diagnosis Clinical Care Guidelines | Cystic Fibrosis Foundationhttps://www.cff.org/medical-professionals/cf-diagnosis-clinical-care-guidelines
To help standardize the diagnosis of both infants with positive newborn screening results and older patients with what may be cystic fibrosis symptoms, the Cystic Fibrosis Foundation worked with CF medical experts to develop guidelines on the steps leading to a confirmed diagnosis. […] The diagnosis of cystic fibrosis is based on clinical signs and symptoms consistent with the disease and objective evidence of cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction. […] The Cystic Fibrosis Foundation assembled a group of 32 CF diagnosis experts from 10 countries to revise prior diagnostic criteria. […] The discussion generated specific consensus statements voted on by conference participants. The statements that met the threshold of 80 percent agreement were enacted. […] The diagnosis of cystic fibrosis is based on clinical signs and symptoms consistent with the disease and objective evidence of cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction.
- #3 Diagnosing Cystic Fibrosis in the 21st CenturyâA Complex and Challenging Taskhttps://www.mdpi.com/2075-4418/14/7/763
Cystic fibrosis (CF) is a chronic and potentially life-threatening condition, wherein timely diagnosis assumes paramount significance for the prompt initiation of therapeutic interventions, thereby ameliorating pulmonary function, addressing nutritional deficits, averting complications, mitigating morbidity, and ultimately enhancing the quality of life and extending longevity. […] This review aims to amalgamate existing knowledge to provide a comprehensive appraisal of contemporary diagnostic modalities pertinent to CF in the 21st century. […] The synthesis underscores that, notwithstanding the availability and strides in diagnostic methodologies, including genetic assays, the sweat test (ST) retains its position as the preeminent diagnostic standard for CF, serving as a robust surrogate for CFTR functionality.
- #3 Cystic Fibrosis Diagnosis and Testing | Cystic Fibrosis News TodayEnvelope iconhttps://cysticfibrosisnewstoday.com/cystic-fibrosis-diagnosis/
Cystic fibrosis (CF) diagnosis is typically a multi-step process that may involve blood tests, genetic analyses, and assessments of sweat to identify the rare genetic disease. […] Most testing for CF is focused on the mutations that cause the disorder, which affect the gene CFTR. […] Newborn screening involves testing babies for CF (and other conditions, simultaneously) within the first few days after birth. […] In the U.S., newborn screening for cystic fibrosis has been implemented in all states. […] The first-line assessment used to screen for potential cases of CF is the immunoreactive trypsinogen test, known as the IRT test. […] Detecting high levels of IRT in the blood can therefore indicate that a baby has CF â but high IRT levels also can occur due to other reasons, like an early or difficult birth.
- #3 Testing for CF | Cystic Fibrosis Foundationhttps://www.cff.org/intro-cf/testing-cf
If you show symptoms of cystic fibrosis or your baby has a positive newborn screen for CF, a sweat test at a CF Foundation-accredited care center can help provide a CF diagnosis by measuring the concentration of salt in your or your baby’s sweat. The test is painless and is the most reliable way to diagnose CF.
- #3 Cystic Fibrosis: Practice Essentials, Background, Pathophysiologyhttps://emedicine.medscape.com/article/1001602-overview
Parameters for the sweat chloride test are as follows: The reference value is less than 40 mmol/L, A value higher than 60 mmol/L of chloride is consistent with CF, A value of 40-60 mmol/L is considered borderline, and the test must be repeated, In babies aged 3 months or younger, a value of 30-60 mEq/L is considered borderline and requires retesting. […] Imaging studies that may be helpful include the following: Radiography (chest, sinus, abdomen), CT of the chest (not yet advised as a routine modality in CF), Ultrasonography, Contrast barium enema. […] Additional tests that may be warranted are as follows: Genotyping, Nasal potential difference measurement, Pulmonary function testing, Bronchoalveolar lavage, Sputum microbiology, Immunoreactive trypsinogen.
- #3 The diagnosis of cystic fibrosis – PubMedhttps://pubmed.ncbi.nlm.nih.gov/28576637/
Establishing the diagnosis of cystic fibrosis (CF) is straight forward in the majority of patients: they present with a clear clinical picture (most frequently chronic respiratory symptoms plus malabsorption), the sweat chloride value is60mmol/L and two known disease causing CFTR mutations are identified. […] In less than 5% of subjects, mainly those with a milder or limited phenotype, the diagnostic process is more complex, because initial diagnostic test results are inconclusive: sweat chloride concentration in the intermediate range, less than 2 CF causing mutations identified or both. […] These patients should be referred to expert centers where bioassays of CFTR function like nasal potential difference measurement or intestinal current measurement can be done. […] Still, in some patients, despite symptoms compatible with CF and some indication of CFTR dysfunction (e.g. only intermediate sweat chloride value), diagnostic criteria are not met (e.g. only 1 CFTR mutation identified).
- #3 The diagnosis of cystic fibrosis – PubMedhttps://pubmed.ncbi.nlm.nih.gov/28576637/
For these subjects, the term CFTR related disorder (CFTR-RD) is used. […] In many countries, nationwide CF newborn screening (NBS) has been introduced. […] In screen positive babies, the diagnosis of CF must be confirmed by a sweat test demonstrating a sweat chloride concentration above 60mmol/L. […] To achieve the benefit of NBS, every baby in whom the diagnosis of CF is confirmed must receive immediate follow-up and treatment in a CF reference center. […] CF NBS is not full proof: some diagnoses will be missed and in some babies the diagnosis cannot be confirmed nor ruled out with certainty. […] Even in 2016, the most reliable and widely available diagnostic test for CF is the measurement of chloride concentration in sweat. […] The method of choice is sweat induction by pilocarpine iontophoresis, followed by sweat collection on a gauze or filter paper or in a Macroduct coil. […] Since mutation specific therapies have become available, it is important to identify the mutations responsible for CF in each individual patient.
- #3 Diagnosis of Cystic Fibrosis Often Missed or Delayed, Especially in Non-White Infants | Lurie Children’shttps://www.luriechildrens.org/en/news-stories/diagnosis-of-cystic-fibrosis-often-missed-or-delayed-especially-in-non-white-infants/
Cystic fibrosis is a progressive genetic disease that damages multiple organs, including the lungs and pancreas. […] Advances in cystic fibrosis diagnosis and treatment have transformed its prognosis from rapid progression and childhood mortality to a chronic multisystem disease of adults with rapidly increasing life expectancy and health span. […] Newborn screening for cystic fibrosis improves nutrition and survival and has been available throughout the United States since 2010. […] It is recommended that infants who screen positive for cystic fibrosis receive their diagnostic evaluation by 28 days of age or earlier. […] Delays in diagnosis of cystic fibrosis increase the risk for severe illness, said Principal Investigator Susanna McColley, MD, pulmonologist at Lurie Childrens and Professor of Pediatrics at Northwestern University Feinberg School of Medicine.